Cunha, C., Gonçalves, S. M., Duarte-Oliveira, C., Leite, L., et al. (2017). IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. Journal of Allergy and Clinical Immunology, 140(3), 867 - 870.e9.

Moreira-Teixeira, L., Sousa, J., McNab, F. W., Torrado, E., et al. (2016). Type i IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-? signaling. Journal of Immunology, 197(12), 4714 - 4726.

Cruz, A., Torrado, E., Carmona, J., Fraga, A. G., et al. (2015). BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells. Vaccine, 33(1), 85 - 91.

Fraga, A. G., Martins, T. G., Torrado, E., Huygen, K., et al. (2012). Cellular immunity confers transient protection in experimental buruli ulcer following BCG or mycolactone-negative mycobacterium ulcerans vaccination. PLoS ONE, 7(3).

Fraga, A. G., Cruz, A., Martins, T. G., Torrado, E., et al. (2011). Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression. Infection and Immunity, 79(1), 421 - 430.

Portaels, F., Meyers, W. M., Ablordey, A., Castro, A. G., et al. (2008). First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Neglected Tropical Diseases, 2(3).

Torrado, E., Fraga, A. G., Castro, A. G., Stragier, P., et al. (2007). Evidence for an intramacrophage growth phase of Mycobacterium ulcerans. Infection and Immunity, 75(2), 977 - 987.

Oliveira, M. S., Fraga, A. G., Torrado, E., Castro, A. G., et al. (2005). Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infection and Immunity, 73(10), 6299 - 6310.

Vilanova, M., Teixeira, L., Caramalho, Í., Torrado, E., et al. (2004). Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology, 111(3), 334 - 342.